Principal Research Scientist
Eupraxia Pharmaceuticals Inc., Canada
Liam MacFarlane obtained his PhD from the University of Bristol, UK working in the group of Prof. Ian Manners on the synthesis of length controlled 1D nanostructures. After his postdoc at the University of Victoria, Canada he joined Eupraxia Pharmaceuticals Inc. to work on their extended-release technology.